生命科学资讯

An Arch-backed biotech raises $53M to fight neurodegeneration

12 former FDA chiefs blast Prasad’s move to toughen vaccine standards

Tracey Beth Høeg, top Makary deputy, named head of FDA drug office

UniQure slides further on outlook for Huntington’s gene therapy

After finding ‘irregularities,’ Bristol Myers to extend key trial of Cobenfy in Alzheimer’s psychosis

Capricor soars on positive results for Duchenne cell therapy

Pharvaris’ pill succeeds in late-stage trial for rare swelling disorder

Richard Pazdur, FDA drug czar, to retire from agency

FDA details plan to scale back animal tests for some antibody drugs

Janux sinks on ‘overreaction’ to prostate cancer data; RFK Jr. replaces ACIP chair

The ‘clever’ tool increasingly getting bigger biotech deals signed

UK agrees to boost drug prices to dodge US pharma tariffs

Regeneron inks gene editing deal with startup Tessera

Belite continues ascent as Stargardt drug hits mark in late-stage trial

With $130M, Protego pushes forward a new type of amyloidosis drug

Expanding access in oncology trials: The case for a paired tissue-plasma approach

Specialty pharmacy’s secret weapon: The unsung power of the enrollment form

From feedstocks to infrastructure, Indiana’s bioeconomy is on the move

Novartis cuts hundreds of jobs; Novo’s dual-acting diabetes drug heading to Phase 3

Otsuka gains approval for first-of-its-kind treatment against rare kidney disease